Filing Details
- Accession Number:
- 0001567619-21-014513
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-05 17:02:21
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-05 17:02:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1500399 | Giovani Twigge | Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-03 | 1,476 | $67.85 | 18,447 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-03 | 8,874 | $141.60 | 27,321 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-03 | 7,036 | $695.34 | 20,285 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-03 | 1,838 | $696.32 | 18,447 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-04 | 5,141 | $178.26 | 23,588 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-04 | 3,068 | $206.94 | 26,656 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-04 | 1,893 | $288.78 | 28,549 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-04 | 1,319 | $700.00 | 27,230 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-04 | 9,242 | $700.30 | 17,988 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-04 | 860 | $701.36 | 17,128 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2021-08-03 | 1,476 | $0.00 | 1,476 | $67.85 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-03 | 8,874 | $0.00 | 8,874 | $141.60 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-04 | 5,141 | $0.00 | 5,141 | $178.26 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-04 | 3,068 | $0.00 | 3,068 | $206.94 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-08-04 | 1,893 | $0.00 | 1,893 | $288.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-13 | No | 4 | M | Direct | |
| 1,512 | 2027-02-13 | No | 4 | M | Direct | |
| 2,866 | 2028-02-13 | No | 4 | M | Direct | |
| 4,118 | 2029-02-13 | No | 4 | M | Direct | |
| 5,677 | 2030-02-13 | No | 4 | M | Direct |
Footnotes
- Includes a total of 21.4780 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
- Represents the weighted average price of the shares sold ranging from a low of $695.00 to a high of $695.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $696.02 to a high of $696.78 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy 1,476 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021.
- Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
- Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.
- Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020.
- Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
- Not applicable.
Billionaire Hedge Funds
